A biodegradable polymer platform for co-delivery of clinically relevant oxaliplatin and gemcitabine
Abstract
Anticancer drugs of gemcitabine and oxaliplatin combined in a clinic regimen (GEMOX regimen) were co-loaded to a biodegradable polymer platform for drug delivery.